Replies to post #296984 on NorthWest Biotherapeutics Inc (NWBO)

[hyperopia]

hi longfellow, back atcha. I don’t think I’ve seen anything more definitive than that, but I can certainly understand your skepticism. I have a different take because it seems to me that things have changed in the last five years since the hold was initiated, and there is not only more of an acceptance of personalized medicine, but an understanding that cell and gene therapies are the future, and the regulators have taken a more supportive and collaborative approach. That’s not to say that Northwest doesn’t need to have all their ducks in a row as this is a highly regulated industry and the regulations are evolving, but I’m fairly optimistic going forward.

BTW - Here’s what the regulators are looking at coming down the pipeline: http://www.summit-re.com/blog/2020/6/12/are-you-ready-preparing-for-gene-and-cell-therapies-coming-down-the-pipeline

I know there has been much debate here about the reasons for the partial hold, but I first invested almost a year after the hold was lifted, so I’ve avoided going down that rabbit hole myself. But since you asked . . . Rk's theory seems reasonable to me:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132792356